Abstract:OBJECTIVE:To investigate the expression of hypoxia-inducible factor (HIF)-1-alpha, HIF-2alpha, and vascular endothelial growth factor (VEGF) in sporadic clear cell renal cell carcinoma (CCRCC) and to analyze the relationship among them.METHODS:Samples of CCRCC were obtained from 107 patients during resection. Immunohistochemistry was used to detect the expression of HIF-1-alpha, HIF-2alpha, and VEGF in the tumor tissues and normal kidney tissues distant from the tumor. The microvessel density (MVD) was observed by microscopy.RESULTS:HIF-1-alpha and HIF-2alpha were not expressed in the normal kidney tissues. However, in the tumor tissues the HIF-1-alpha positive rate was 69.2% (74/107), significantly lower than that of the HIF-2-alpha (80.5%, 88/107, P = 0.001), the VEGF positive rate was 78.5% (84/107). The VEGF positive rate of the HIF-1-alpha-positive group was 90.5%, significantly higher than that of the HIF-1-alpha-negative group (51.5%, P = 0.001). The VEGF positive rate of the HIF-2-alpha-positive group was 89.8%, significantly higher than that of the HIF-1-alpha-negative group (26.3%, P = 0.001). The MVD of the 64 HIF-1alpha, HIF-2alpha, and VEGF positive samples was 697, significantly higher than that of the 13 HIF-1alpha, HIF-2alpha, and VEGF negative samples (391, P = 0.001). The MVD of the HIF-2alpha positive samples was 678 +/- 324, significantly higher than that of the HIF-2alpha negative samples (383 +/- 293, P = 0.001). The MVD of the VEGF positive samples was 692 +/- 325, significantly higher than that of the VEGF negative samples (384 +/- 269, P = 0.001). Spearman correlation analysis showed that MVD was strongly positively correlated with HIF-2alpha and VEGF. Mann-Whitney U test showed that HIF-1alpha and HIF-2alpha were not correlated with the staging of CCRCC.CONCLUSION:HIF-2alpha is expressed more frequently in sporadic CCRCC than HIF-1alpha. Both HIF-1alpha and HIF-2alpha upregulate the VEGF expression and angiogenesis, especially HIF-2alpha.

A Study on the Expression of Vascular Epidermal Growth Factor and Angiotensin II in Clear Cell Renal Cell Carcinoma and Sunitinib in Renal Cell Treatment

Effect of transcatheter arterial chemoembolization on angiogenesis and expression of vascular endothelial growth factor in cervical squamous cell carcinoma

Bioinformatics Analyses of the Role of Vascular Endothelial Growth Factor in Patients with Non-Small Cell Lung Cancer.

Expression of Vascular Endothelial Growth Factor in Renal Cell Carcinoma and Its Clinical Implications

Expression and clinical study of vascular endothelial growth factor and its receptors FLT-1, FLK-1/KDR in non-small cell lung cancer

The expression and clinical significance of Survivin and VEGF in renal cell carcinoma

Impact of Serum Vascular Endothelial Growth Factor and Interleukin-6 on Treatment Response to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients with Non-Small-cell Lung Cancer

Enhanced expression of caveolin-1 possesses diagnostic and prognostic value and promotes cell migration, invasion and sunitinib resistance in the clear cell renal cell carcinoma

Prognostic and predictive significance of VEGF, CD31, and Ang-1 in patients with metastatic clear cell renal cell carcinoma treated with first-line sunitinib

Expression and Clinical Significance of Vascular Endothelial Growth Factor and Epidermal Growth Factor in Non-Small Cell Lung Cancer

Expression of Angiopoietin and VEGF in Cervical Cancer and Its Clinical Significance

Key sunitinib-related biomarkers for renal cell carcinoma

AUY922 improves sensitivity to sunitinib in clear cell renal cell carcinoma based on network pharmacology and in vitro experiments

The Angiotensin-Converting Enzyme 2 in Tumor Growth and Tumor-Associated Angiogenesis in Non-Small Cell Lung Cancer

Clinical use of vascular endothelial growth factor receptor inhibitors for the treatment of renal cell carcinoma

[Expression of Hypoxia-Inducible Factor-1-alpha, Hypoxia-Inducible Factor-2Alpha and Vascular Endothelial Growth Factor in Sporadic Clear Cell Renal Cell Renal Cell Carcinoma and Their Significance in the Pathogenesis Thereof].

Expressions of Serum Angiogenin-1 and Angiogenin-2 in Patients with Renal Cell Carcinoma and Their Clinical Significance

Vascular Endothelial Growth Inhibitor, a Cytokine of the Tumor Necrosis Factor Family, is Associated With Epithelial-Mesenchymal Transition in Renal Cell Carcinoma.

The Expressions and Their Significances of CD147,matrix Metalloproteinase-9 and Vascular Endothelial Growth Factor in Renal Cell Carcinoma

CD147 and VEGF expression in advanced renal cell carcinoma and their prognostic value.

Expression and significance of VEGF and PCNA in renal cell carcinoma